US$ 22.34
retatrutide vision side effects Unapproved weight loss drug causes extreme It isn't approved by the
Description
R.CancelasJ.et al (2009)
Novo Nordisk: CagriSema Cagrilinitide is an analogue (a drug made to mimic a molecule already present in the body) of amylin, which acts as an agonist for calcitonin receptors

FDA-Approved : It is FDA-approved for type 2 diabetes, chronic weight management and obstructive sleep apnea (OSA), ensuring safety and efficacy for its intended use

Vomiting: Alongside nausea, some individuals may experience vomiting, particularly in the initial weeks of treatment

doi: 10.1080/17425255.2020.1767067 [DOI] [PubMed] [Google Scholar] 30
